Literature DB >> 25935136

LH (Trp8Arg/Ile15Thr), LHR (insLQ) and FSHR (Asn680Ser) polymorphisms genotypic prevalence in women with endometriosis and infertility.

Carla Regina Schmitz1, Carlos Augusto Bastos de Souza, Vanessa Krebs Genro, Ursula Matte, Emily de Conto, João Sabino Cunha-Filho.   

Abstract

PURPOSE: To verify if polymorphisms of LH (Trp8Arg/Ile15Thr), LH receptor (insLQ), and FSH receptor (Asn680Ser) are associated with endometriosis and infertility.
METHODS: This is a prospective case-control study. Sixty-seven patients with endometriosis and infertility (study group) and 65 healthy fertile patients (control group) were enrolled in the study between July 2010 and July 2013. All patients had their endometriosis diagnosis made or excluded by laparoscopic surgery; study group was submitted to the surgery for infertility investigation and control group for tubal ligation. Day-3 serum hormones were collected from all patients. Analysis of nucleotide mutations for LH polymorphisms (Trp8Arg and Ile15Thr), LHR polymorphism (insLQ), and FSHR polymorphism (Asn680Ser) were performed by PCR.
RESULTS: Day-3 FSH, estradiol and LH serum levels were not different between the groups, while CA-125 was higher in patients with endometriosis and infertility. All polymorphisms studied were in Hardy-Weinberg equilibrium. The prevalence of insLQ was significantly higher in patients with endometriosis and infertility (P = 0.005). Allele occurrence in control group was 0.10 versus 0.25 in infertile endometriosis group (P = 0.001). There was no difference regarding Trp8Arg/Ile15Thr (P > 0.05) and Asn680Ser (P > 0.05) prevalence between groups.
CONCLUSION: This is the first time that prevalence of insLQ was shown to be higher in patients with endometriosis and infertility than in healthy fertile patients. There was no difference in LH and FSHR polymorphisms' prevalence between groups.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25935136      PMCID: PMC4491084          DOI: 10.1007/s10815-015-0477-3

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  54 in total

Review 1.  Medical treatment of endometriosis.

Authors:  K S Moghissi
Journal:  Clin Obstet Gynecol       Date:  1999-09       Impact factor: 2.190

2.  Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype.

Authors:  M Perez Mayorga; J Gromoll; H M Behre; C Gassner; E Nieschlag; M Simoni
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

3.  Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation.

Authors:  Hermann M Behre; Robert R Greb; Andrea Mempel; Barbara Sonntag; Ludwig Kiesel; Petra Kaltwasser; Ewald Seliger; Friedrich Röpke; Jörg Gromoll; Eberhard Nieschlag; Manuela Simoni
Journal:  Pharmacogenet Genomics       Date:  2005-07       Impact factor: 2.089

4.  A new contributing factor to polycystic ovary syndrome: the genetic variant of luteinizing hormone.

Authors:  J S Tapanainen; R Koivunen; B C Fauser; A E Taylor; R N Clayton; M Rajkowa; D White; S Franks; L Anttila; K S Pettersson; I T Huhtaniemi
Journal:  J Clin Endocrinol Metab       Date:  1999-05       Impact factor: 5.958

5.  There is no complete linkage between the polymorphisms N680S and T307A of the follicular stimulating hormone receptor gene in fertile women.

Authors:  Gustavo P Rodini; Vanessa K Genro; Ursula Matte; Fernanda S Pereira; João Paolo Bilibio; Camila Greggianin; Carlos A B Souza; João Sabino Cunha-Filho
Journal:  J Assist Reprod Genet       Date:  2010-11-10       Impact factor: 3.412

Review 6.  Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization.

Authors:  Antonio La Marca; Giovanna Sighinolfi; Cindy Argento; Valentina Grisendi; Livio Casarini; Annibale Volpe; Manuela Simoni
Journal:  Fertil Steril       Date:  2013-02-04       Impact factor: 7.329

Review 7.  Endometriosis and mechanisms of pelvic pain.

Authors:  Fred M Howard
Journal:  J Minim Invasive Gynecol       Date:  2009 Sep-Oct       Impact factor: 4.137

8.  Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement.

Authors:  Julian Little; Julian P T Higgins; John P A Ioannidis; David Moher; France Gagnon; Erik von Elm; Muin J Khoury; Barbara Cohen; George Davey-Smith; Jeremy Grimshaw; Paul Scheet; Marta Gwinn; Robin E Williamson; Guang Yong Zou; Kim Hutchings; Candice Y Johnson; Valerie Tait; Miriam Wiens; Jean Golding; Cornelia van Duijn; John McLaughlin; Andrew Paterson; George Wells; Isabel Fortier; Matthew Freedman; Maja Zecevic; Richard King; Claire Infante-Rivard; Alex F Stewart; Nick Birkett
Journal:  J Clin Epidemiol       Date:  2009-02-12       Impact factor: 6.437

9.  Genetic polymorphisms influence the ovarian response to rFSH stimulation in patients undergoing in vitro fertilization programs with ICSI.

Authors:  Radia Boudjenah; Denise Molina-Gomes; Antoine Torre; Marianne Bergere; Marc Bailly; Florence Boitrelle; Stéphane Taieb; Robert Wainer; Mohamed Benahmed; Philippe de Mazancourt; Jacqueline Selva; François Vialard
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

10.  Study in 1790 Baltic men: FSHR Asn680Ser polymorphism affects total testes volume.

Authors:  M Grigorova; M Punab; O Poolamets; S Sõber; V Vihljajev; B Žilaitienė; J Erenpreiss; V Matulevičius; I Tsarev; M Laan
Journal:  Andrology       Date:  2012-11-29       Impact factor: 3.842

View more
  2 in total

Review 1.  Sex hormone-related polymorphisms in endometriosis and migraine: A narrative review.

Authors:  Joy-Fleur van der Vaart; Gabriele Susanne Merki-Feld
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

Review 2.  Hormonal treatments for endometriosis: The endocrine background.

Authors:  Silvia Vannuccini; Sara Clemenza; Margherita Rossi; Felice Petraglia
Journal:  Rev Endocr Metab Disord       Date:  2021-08-17       Impact factor: 9.306

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.